EP4065234A1 - Compositions vétérinaires de type shampooing - Google Patents
Compositions vétérinaires de type shampooingInfo
- Publication number
- EP4065234A1 EP4065234A1 EP20811371.2A EP20811371A EP4065234A1 EP 4065234 A1 EP4065234 A1 EP 4065234A1 EP 20811371 A EP20811371 A EP 20811371A EP 4065234 A1 EP4065234 A1 EP 4065234A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- weight
- composition according
- composition
- chosen
- veterinary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 115
- 239000002453 shampoo Substances 0.000 title abstract description 13
- 244000248557 Ophiopogon japonicus Species 0.000 claims abstract description 29
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 16
- 238000005406 washing Methods 0.000 claims abstract description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 244000052616 bacterial pathogen Species 0.000 claims description 15
- 229960003237 betaine Drugs 0.000 claims description 14
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 12
- 241000282326 Felis catus Species 0.000 claims description 12
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 12
- 239000003945 anionic surfactant Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000013543 active substance Substances 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 239000002736 nonionic surfactant Substances 0.000 claims description 7
- 125000002091 cationic group Chemical group 0.000 claims description 6
- 241000794282 Staphylococcus pseudintermedius Species 0.000 claims description 5
- 229940079868 disodium laureth sulfosuccinate Drugs 0.000 claims description 5
- YGAXLGGEEQLLKV-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-2-sulfonatobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)CC(C([O-])=O)S([O-])(=O)=O YGAXLGGEEQLLKV-UHFFFAOYSA-L 0.000 claims description 5
- 229940007636 sodium lauroyl methyl isethionate Drugs 0.000 claims description 5
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 claims description 5
- NVIZQHFCDBQNPH-UHFFFAOYSA-M sodium;2-dodecanoyloxypropane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)CS([O-])(=O)=O NVIZQHFCDBQNPH-UHFFFAOYSA-M 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 241000191967 Staphylococcus aureus Species 0.000 claims description 4
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 claims description 4
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 4
- 229940096501 sodium cocoamphoacetate Drugs 0.000 claims description 4
- 229940079781 sodium cocoyl glutamate Drugs 0.000 claims description 4
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 229940073499 decyl glucoside Drugs 0.000 claims description 3
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims description 2
- 229920000926 Galactomannan Polymers 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 150000008131 glucosides Chemical class 0.000 claims description 2
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 claims description 2
- 229940048848 lauryl glucoside Drugs 0.000 claims description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 abstract description 3
- -1 alkali metal salts Chemical class 0.000 description 19
- 150000003839 salts Chemical class 0.000 description 19
- 241000282472 Canis lupus familiaris Species 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 11
- 235000000346 sugar Nutrition 0.000 description 10
- 239000004094 surface-active agent Substances 0.000 description 9
- 150000008163 sugars Chemical class 0.000 description 8
- 125000000129 anionic group Chemical group 0.000 description 7
- 230000004888 barrier function Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 4
- 244000303965 Cyamopsis psoralioides Species 0.000 description 4
- 229920002670 Fructan Polymers 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 206010001488 Aggression Diseases 0.000 description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000016571 aggressive behavior Effects 0.000 description 3
- 125000002947 alkylene group Chemical group 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- 229940101267 panthenol Drugs 0.000 description 3
- 235000020957 pantothenol Nutrition 0.000 description 3
- 239000011619 pantothenol Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229940094944 saccharide isomerate Drugs 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- OTKWLUKIHNEGIG-UHFFFAOYSA-N 2-[3-(hexadecanoylamino)propyl-dimethylazaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O OTKWLUKIHNEGIG-UHFFFAOYSA-N 0.000 description 1
- QVRMIJZFODZFNE-UHFFFAOYSA-N 2-[dimethyl-[3-(octadecanoylamino)propyl]azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O QVRMIJZFODZFNE-UHFFFAOYSA-N 0.000 description 1
- ZKWJQNCOTNUNMF-QXMHVHEDSA-N 2-[dimethyl-[3-[[(z)-octadec-9-enoyl]amino]propyl]azaniumyl]acetate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O ZKWJQNCOTNUNMF-QXMHVHEDSA-N 0.000 description 1
- TYIOVYZMKITKRO-UHFFFAOYSA-N 2-[hexadecyl(dimethyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O TYIOVYZMKITKRO-UHFFFAOYSA-N 0.000 description 1
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 1
- CNIGBCBFYDWQHS-QXMHVHEDSA-N 3-[dimethyl-[3-[[(z)-octadec-9-enoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O CNIGBCBFYDWQHS-QXMHVHEDSA-N 0.000 description 1
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 229940120146 EDTMP Drugs 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 240000004110 Russelia equisetiformis Species 0.000 description 1
- 240000000961 Setaria parviflora Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Chemical class 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 230000007073 chemical hydrolysis Effects 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- QLBHNVFOQLIYTH-UHFFFAOYSA-L dipotassium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [K+].[K+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O QLBHNVFOQLIYTH-UHFFFAOYSA-L 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 description 1
- 229940079857 disodium cocoamphodipropionate Drugs 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 229940079881 disodium lauroamphodiacetate Drugs 0.000 description 1
- QKQCPXJIOJLHAL-UHFFFAOYSA-L disodium;2-[2-(carboxylatomethoxy)ethyl-[2-(dodecanoylamino)ethyl]amino]acetate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)NCCN(CC([O-])=O)CCOCC([O-])=O QKQCPXJIOJLHAL-UHFFFAOYSA-L 0.000 description 1
- WSJWDSLADWXTMK-UHFFFAOYSA-L disodium;2-[2-(carboxylatomethoxy)ethyl-[2-(octanoylamino)ethyl]amino]acetate Chemical compound [Na+].[Na+].CCCCCCCC(=O)NCCN(CC([O-])=O)CCOCC([O-])=O WSJWDSLADWXTMK-UHFFFAOYSA-L 0.000 description 1
- HQYLVDYBSIUTBB-UHFFFAOYSA-L disodium;3-[2-(2-carboxylatoethoxy)ethyl-[2-(dodecanoylamino)ethyl]amino]propanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)NCCN(CCC([O-])=O)CCOCCC([O-])=O HQYLVDYBSIUTBB-UHFFFAOYSA-L 0.000 description 1
- GEGKMYLSPGGTQM-UHFFFAOYSA-L disodium;3-[2-(2-carboxylatoethoxy)ethyl-[2-(octanoylamino)ethyl]amino]propanoate Chemical compound [Na+].[Na+].CCCCCCCC(=O)NCCN(CCC([O-])=O)CCOCCC([O-])=O GEGKMYLSPGGTQM-UHFFFAOYSA-L 0.000 description 1
- KJDVLQDNIBGVMR-UHFFFAOYSA-L disodium;3-[2-aminoethyl-[2-(2-carboxylatoethoxy)ethyl]amino]propanoate Chemical compound [Na+].[Na+].[O-]C(=O)CCN(CCN)CCOCCC([O-])=O KJDVLQDNIBGVMR-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 229940058180 edetate dipotassium anhydrous Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical class OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 150000005619 secondary aliphatic amines Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001578 tight junction Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
Definitions
- the present invention relates to the veterinary field and, more particularly, to shampoo-type compositions comprising an active agent obtained from Ophiopogon japonicus and an amphoteric surfactant, intended for non-human mammals. It also relates to a method for washing the coat of non-human mammals by applying said shampoo-type compositions to the coat and / or the skin.
- shampoo comprising said active agent suitable for non-human mammals, in particular dogs and cats.
- the skin and coat of non-human mammals protect them against external aggressions. Their maintenance is therefore very important for the well-being, even the health, of non-human mammals.
- the skin and hair of domestic animals such as dogs and cats are covered with a layer of fatty acids and waxes which participate in the barrier function, thus having a protective role for the skin against external aggressions, and which gives the silky appearance of the coat.
- a veterinary shampoo must therefore be effective in terms of washing power for the skin and the coat, without causing irritation or any other disorder of the skin. It must also preserve or maintain the barrier function and / or the silky appearance of the coat. The skin must in particular retain its protective effect against external aggressions.
- staphylococci there are bacteria which can be pathogenic or become pathogenic if in too large numbers, such as staphylococci, for dogs and / or cats, and which require special treatments for their reduction or elimination.
- staphylococci are represented mainly by S. pseudintermedius.
- the Applicant proposes a novel composition of shampoo type comprising an active agent obtained from Ophiopogon japonicus and at least one amphoteric surfactant chosen from betaines.
- the present invention therefore relates to a veterinary composition
- a veterinary composition comprising an active agent obtained from Ophiopogon japonicus and at least one amphoteric surfactant chosen from betaines intended to be used as a shampoo for a non-human mammal, in particular a dog or a cat. .
- Another object of the invention therefore relates to a method for cleaning and / or washing the skin and / or the coat of a non-human mammal, and in particular a dog or a cat, by applying the composition of the present invention to the skin and / or coat of said mammal.
- Another subject of the invention relates to the use of a composition as defined in the present application or to a process using said composition to reduce and / or prevent the presence of pathogenic bacteria and / or the formation and / or adhesion.
- biofilms of pathogenic bacteria in a non-human mammal such as a dog or cat.
- the invention as described in the present application relates to a veterinary shampoo-type composition
- a veterinary shampoo-type composition comprising an active agent obtained from Ophiopogon japonicus and at least one amphoteric surfactant chosen from betaines.
- Ophiopogon japonicus is a perennial herbaceous species, low and abundant, with a rhizome of the Liliaceae family. It is cultivated as a covering ornamental plant with a tuberous rhizome with many uses in traditional Chinese medicine.
- the species is native to Japan and Korea, and is also cultivated in Vietnam and China, especially in the provinces of Sichuan, Zhejiang and Hubei. It is called Muguet du Japon in France, and Mondo grass, Fountain plant, Monkey grass or Dwarf lilyturf in English.
- the tuberous root is a few centimeters long; it is light yellow to yellow-brown on the outside, with longitudinal wrinkles. It has a faint odor, and its taste is slightly sweet and mucilaginous.
- Ophiopogon japonicus The roots of Ophiopogon japonicus come from cultivated channels in China and Vietnam. Extracts of Ophiopogon japonicus are known in cosmetics for the skin, in particular in patent EP2271311, as a moisturizer by acting on the rate of NMF (Natural Moisturizing Factors) and on the formation of tight junctions of the layers cutaneous. It has also been described in application WO 2017/121965 that extracts of Ophiopogon japonicus can be used to treat atopic dermatitis.
- NMF Natural Moisturizing Factors
- active principle or “active ingredient” or “extract” within the meaning of the invention, is meant at least one molecule, preferably a set of molecules exhibiting an effect on the cells of the skin.
- active principle obtained from Ophiopogon japonicus within the meaning of the invention is meant any molecule or mixture of molecules obtained from Ophiopogon japonicus. They may be molecules native to the plant or molecules obtained by any type of transformation of the native molecules of the plant, for example by hydrolysis.
- the active principle according to the invention is preferably a hydrolyzate.
- hydrolyzate means any extract obtained from Ophiopogon japonicus, obtained with a process comprising at least one enzymatic or chemical hydrolysis step of Ophiopogon japonicus, preferably at least one enzymatic hydrolysis step.
- Ophiopogon japonicus is meant all or part of the plant. It can be the whole plant or part of the plant. Preferably, they are tubers of Ophiopogon japonicus.
- oligosaccharides oligomers formed from a number of monosaccharides per glycosidic bond, the number of monosaccharide units being less than 25 units.
- polysaccharides is understood to mean polymers consisting of several oses linked together by osidic bonds, the number of monosaccharide units being greater than 25 units.
- the active principle obtained from Ophiopogon japonicus used in the composition according to the invention is preferably an active principle obtained from Ophiopogon japonicus comprising sugars. Even more preferably, it comprises fructans, and more particularly it comprises at least 57% of fructans by weight relative to the weight of the total sugars of the active principle, even more preferably at least 80%.
- Fructans are polysaccharides made up of fructose and glucose.
- the sugars contained in the active principle preferably consist of 45 to 80% of fructose, of 20 to 50% of glucose and of 0 to 5% of galactose. These sugars can be in the form of monomers, oligomers and polymers.
- the sugars contained in the active principle are oligo and polysaccharides with molecular weights of less than 400 kDa in the form of fructosans.
- the active principle according to the invention comprises oligo and polysaccharides with molecular weights of less than 400 kDa in the form of fructosans, representing at least 57% by weight of the sugars present in the active principle.
- the active principle is obtained from tubers of Ophiopogon japonicus.
- the active principle used to prepare the composition according to the invention is in the form of a powder, in particular a light-colored powder, and has at least one of the following characteristics, preferably all of them:
- the dry matter content can be measured by passing a sample in an oven at 105 ° C. until a constant weight is obtained.
- the overall sugar content can be determined by the DUBOIS method on a range of fructose (Dubois M. et al., Analytical Chemistry, 28, 3, 350-356, 1956).
- the characterization of the molar mass of the carbohydrates present in the active principle of the present invention can be carried out by HPLC method and the determination of the simple sugars by ionic liquid chromatography.
- the molar masses of the carbohydrates are evaluated by comparing the retention times of the peaks detected in the samples of the active principle with the retention times of the standards injected beforehand.
- the operating conditions are preferably the following:
- the active principle according to the invention is preferably an active principle obtained in aqueous medium from tubers of Ophiopogon japonicus.
- aqueous medium obtained in an aqueous medium is meant a medium containing mainly water, or a basic or acidic aqueous medium. In particular, it is not an oil or an essential oil.
- the active principle according to the invention is a hydrolyzate of Ophiopogon japonicus, preferably an enzymatic hydrolyzate.
- the active principle according to the invention is a hydrolyzate of tubers of Ophiopogon japonicus, preferably an enzymatic hydrolyzate of tubers of Ophiopogon japonicus.
- the active principle useful according to the invention can be obtained by implementing the following steps:
- Enzymatic inactivation can be followed by one or more filtration and / or concentration steps.
- the active principle can be obtained in liquid form or in powder form by atomization or lyophilization. Preferably, it is atomized, in the presence of an atomization adjuvant of maltodextrin type, and used in powder form.
- the parameters of the various steps must be adjusted in order to obtain active ingredients exhibiting the characteristics of the invention, in particular the presence of fructans having a molecular weight of less than 400 kDa.
- the active principle is atomized with maltodextrin; it is thus in the form of a powder (before formulation in the composition according to the invention).
- composition according to the invention advantageously comprises at least 0.1% by weight of active principle obtained from Ophiopogon japonicus, according to the present invention, preferably between 0.1 and 1% (or between 0.1 and 0.8 %) by weight relative to the total weight of the composition, and more particularly between 0.1 and 0.6% by weight relative to the total weight of the composition.
- amphoteric surfactants of betaine type are preferably chosen from alkyl (C8-C20) betaines, alkyl (C8-C20) amidoalkyl (C1-C8) betaines, alkyl (C8- C20) amidoalkyl (C1-C8) sulfobetaines, alkyl (C8-C20) amidoalkyl (Cl-
- hydroxysulfobetaines C6) hydroxysulfobetaines, sulfobetaines and hydroxysulfobetaines.
- Coco-betaine Laury betaine, Cetyl-betaine, Coco / oleamidopropyl-betaine Cocamidopropyl-betaine, Palmitamidopropyl-betaine, Stearamidopropyl- betaine, Cocamidoamido-betaine, Cocamidoamido-betaine, Cocamidoamido-betaine, propyl-hydroxy-sultaine, Oleamidopropyl-hydroxysultaine Coco-hydroxysultaine, Laurylhydroxy-sultaine, Coco-sultaine, alone or in mixtures.
- said at least one amphoteric surfactant of betaine type is chosen from alkyl (C8-C20) amidoalkyl (C1-C6) betaines, alkyl (C8-C20) amidoalkyl (C1-C6) sulfobetaines (also called alkyl (C8) -C20) amidoalkyl (C1-C6) sultaines), alkyl (C8- C20) amidoalkyl (C1-C6) hydroxysulfobetaines (also called alkyl (C8- C20) amidoalkyl (C1-C6) hydroxysultaines).
- amphoteric surfactant of betaine type is chosen from alkyl (C8-C20) amidoalkyl (C1-C6) hydroxysulfobetaines. It is more specifically cocamidopropyl-hydroxy-sultaine (in particular sold by the company Seppic under the trade name “Amonyl 675 SB”).
- composition according to the present invention advantageously comprises at least 3% of amphoteric surfactants of betaine type, preferably between 4 and 15% relative to the total weight of the composition, and more particularly between 4 and 12% relative to the total weight of the composition. .
- shampoo includes any composition intended to cleanse the hair or skin of non-human mammals and requires rinsing with water after application to the non-human mammal.
- shampoos have certain essential characteristics.
- a shampoo has wetting, foaming and detergent properties in order to ensure a satisfactory cleansing of the skin and the coat.
- the shampoo composition according to the invention contains, in addition to said at least one amphoteric surfactant chosen from betaines, one or other additional surfactants, preferably at least one additional surfactant.
- the shampoo composition according to the invention contains, in addition to said at least one amphoteric surfactant chosen from betaines, at least one additional anionic surfactant, at least one additional amphoteric surfactant (ie different from said at least one surfactant amphoteric chosen from betaines), at least one additional nonionic surfactant, or a mixture thereof.
- anionic surfactants use is preferably made of anionic sulphonate (s) or carboxylic surfactants (s).
- the anionic sulphonate surfactants are anionic surfactants comprising at least one sulphonate function (-SO 3 H or -SO 3 -) and not comprising a cationic function.
- the anionic sulphonate surfactants which can be used, alone or as mixtures, in the context of the present invention, are the salts (in particular alkali metal salts, in particular sodium, ammonium salts, amine salts, amino alcohol salts or magnesium salts) alkylsulfonates, alkylsulfosuccinates, alkylethersulfosuccinates, acyl isethionates, acyl methylisethionates, methyl acyl taurates; the alkyl or acyl radical of all these different compounds preferably comprising from 8 to 24 carbon atoms, and the aryl radical preferably denoting a phenyl or benzyl group.
- the average number of ethylene oxide or propylene oxide groups can range in particular from 2 to 50 and more particularly from 2 to 10.
- the anionic carboxylic surfactants are anionic surfactants comprising at least one carboxylic function (-COOH) optionally in the form of a salt (-COO-).
- the anionic surfactants of carboxylic type other than the surfactants preferably do not comprise a sulphate or sulphonate function and can in particular be chosen from D-alkyl galactoside uronic acids and their salts, polyoxyalkylenated (C6-C24) alkyl ether carboxylic acids, polyoxyalkylenated (C6-C24) aryl ether carboxylic acids and their salts, polyoxyalkylenated (C6-C24) alkyl amido ether carboxylic acids and their salts, in particular those comprising from 2 to 50 alkylene oxide groups, in particular ethylene such that the compounds offered by the company KAO under the names AKYPO, acyl (C6-C24) sarcosinates and their salts, acyl (C6-C24) lactylates and their salts and acyl (C6-C24) glutamates.
- D-alkyl galactoside uronic acids and their salts
- esters of alkyl (C6-C24) carboxylic polyglycosides such as alkylglucoside acetates, alkylglucoside citrates and alkylpolyglycoside tartrates.
- alkyl (C6-C24) carboxylic polyglycosides such as alkylglucoside acetates, alkylglucoside citrates and alkylpolyglycoside tartrates.
- Such products are sold in particular under the names Eucarol APG / EC and Eucarol APG / ET by the company Lamberti and Plantapon LGC SORB by the company Cognis.
- the salts are in particular chosen from alkali metal salts, in particular sodium, ammonium salts, amine salts, amino alcohol salts such as triethanolamine or monoethanolamine and magnesium salts.
- Use is preferably made of polyoxyalkylenated (C6-C24) alkyl ether carboxylic acids and their salts, polyoxyalkylenated (C6-C24) alkyl amido ether carboxylic acids and their salts, in particular those comprising from 2 to 15 alkylene oxide groups, the esters of alkyl (C6-C24) carboxylic polyglycosides and their salts and acyl (C6-C24) glutamates and their salts and mixtures thereof.
- Use is more particularly made of polyoxyalkylenated (C6-C24) alkyl ether carboxylic acids and their salts, polyoxyalkylenated (C6-C24) alkyl amido ether carboxylic acids, in particular those comprising from 2 to 15 alkylene oxide groups, and their salts and their salts. mixtures.
- the composition according to the invention comprises at least one anionic surfactant chosen from alkylethersulfosuccinates, acyl methylisethionates, methyl acyl taurates.
- anionic surfactant chosen from alkylethersulfosuccinates, acyl methylisethionates, methyl acyl taurates.
- the anionic surfactants can be present in an amount of 2% to 30% by weight, preferably 4 to 25% by weight, particularly 6 to 20% by weight, more particularly 8 to 15%, better still 10 to 14% by weight relative to the total weight of the composition.
- the composition comprises disodium laureth sulfosuccinate, in particular sold by the company Evonik under the trade name Rewopol SB 30 B.
- the amount of disodium laureth sulfosuccinate can be between 1 and 5%, preferably between 2 and 4%. by weight relative to the total weight of the composition.
- the composition comprises sodium lauroyl methylisethionate, in particular sold by the company Innospec under the trade name Iselux Flakes.
- the amount of sodium lauroyl methylisethionate can be between 3 and 7%, preferably between 4 and 5% by weight relative to the total weight of the composition.
- the composition comprises sodium methyl cocoyl taurate, in particular sold by the company Innospec under the trade name Pureact WS Conc.
- the amount of sodium methyl cocoyl taurate can be between 3 and 7%, preferably between 4 and 5% by weight relative to the total weight of the composition.
- the composition comprises a mixture of disodium laureth sulfosuccinate, sodium lauroyl methylisethionate, and sodium methyl cocoyl taurate, in the amounts of each as indicated above.
- amphoteric surfactants other than those of betaine type which can be used in the present invention can be in particular (non-limiting list) secondary or tertiary aliphatic amines, in which the aliphatic radical is a linear or branched chain comprising 8 to 22 atoms. carbon and containing at least one water-solubilizing anionic group (eg carboxylate, sulfonate, sulfate, phosphate or phosphonate).
- aliphatic radical is a linear or branched chain comprising 8 to 22 atoms. carbon and containing at least one water-solubilizing anionic group (eg carboxylate, sulfonate, sulfate, phosphate or phosphonate).
- These compounds can be the following compounds: sodium cocoamphoacetate, sodium cocoyl glutamate, disodium cocoamphodiacetate, disodium Lauroamphodiacetate, Disodium caprylamphodiacetate, disodium capryloamphodiacetate, disodium cocoamphodipropionate, disodium lauroamphodipropionate, disodium caprylamphodipropionate, disodium capryloamphodipropionate, lauroamphodipropionic acid, cocoamphodipropionic acid (INCI names).
- the amphoteric surfactant (s) other than those of betaine type are chosen from sodium cocoamphoacetate, sodium cocoyl glutamate and their mixture.
- amphoteric surfactant other than those of betaine type, and in particular sodium cocoamphoacetate and / or sodium cocoyl glutamate, may be present in the composition according to the invention in amounts ranging from 0.1 to 10% by weight, preferably from 1 to 5% by weight, and more particularly from 2 to 4% by weight and better still from 2 to 3% by weight relative to the total weight of the composition .
- nonionic surfactants which can be combined with these compounds and with these compositions, particular mention will be made of alkylglucosides, alkylpolyglucosides, castor oil derivatives, polysorbates, coconut amides, N-alkylamines, or amine oxides.
- the composition according to the invention comprises at least one nonionic surfactant chosen from alkyl (poly) glucosides, and in particular decylglucoside, laurylglucoside, cocoylglucoside or capryl / caprylyl polyglucoside.
- the composition according to the invention preferably comprises decylglucoside.
- the nonionic surfactant (s) may be present in the composition according to the invention in amounts ranging from 0.1 to 15% by weight, preferably from 1 to 10% by weight, and more particularly from 3 to 8% by weight and better still from 5 to 7% by weight relative to the total weight of the composition.
- the composition is an aqueous composition. It can comprise water in a content ranging from 30 to 95% by weight, relative to the total weight of the composition, preferably ranging from 40 to 90% by weight, preferably ranging from 50 to 85% by weight.
- the composition according to the invention can comprise other compounds such as modified or unmodified guar gums. More particularly, the composition according to the invention comprises cationic galactomannan gums (which are described more particularly in patents US3589578 and US4031307). Mention may be made of guar gums comprising cationic trialkylammonium groups. Guar gums modified with a salt (for example a chloride) of 2,3- are used, for example. epoxypropyl trimethylammonium. Such products are marketed in particular under the name JAGUAR EXCEL by the company Solvay or SACI-CFPA. The modified or unmodified guar gums are present in the composition advantageously in amounts of between 0.01 and 0.5% by weight, preferably between 0.05 and 0.15%, and better still between 0.08 and 0, 1% by weight, relative to the total weight of the composition
- composition according to the invention can comprise one or more chelating agents, which can be chosen in particular from EDTA (ethylenediaminetetraacetic acid) and its salts such as disodium EDTA and dipotassium EDTA, phosphate compounds such as sodium metaphosphate , sodium hexametaphosphate, tetrapotassium pyrophosphate, phosphonic acids and their salts such as salts of ethylenediaminetetramethylenephosphonic acid, and mixtures thereof.
- EDTA ethylenediaminetetraacetic acid
- phosphate compounds such as sodium metaphosphate , sodium hexametaphosphate, tetrapotassium pyrophosphate
- phosphonic acids and their salts such as salts of ethylenediaminetetramethylenephosphonic acid, and mixtures thereof.
- the shampoo-type compositions according to the invention can also comprise agents which are beneficial for the skin or the coat. These ingredients are generally introduced into the composition to improve the qualities of the feel of the keratin fiber of the coat or of the skin or to promote hydration of the latter. Cationic polymers, silicones and emollients, such as polyols, constitute in this context the most commonly used ingredients. One can also use soothing agents, such as panthenol.
- composition may also comprise thickening or suspending agents, such as copolymers of acrylic or methacrylic acid and of an alkyl acrylate chain crosslinked with an allyl ether of pentaerythritol or of sucrose. Mention may in particular be made of the acrylate / C10-30 alkyl acrylate crosspolymer compound (INCI name).
- composition according to the invention may also comprise other compounds, in particular chosen from saccharides, oligosaccharides, hydrolyzed or unmodified polysaccharides, modified or not, such as saccharide isomerate, amino acids, oligopeptides, peptides, hydrolyzed or unmodified proteins, modified or not, branched or unbranched fatty acids and alcohols, animal, vegetable or mineral oils or waxes, ceramides and pseudo-ceramides, hydroxylated organic acids, antioxidants, anti-free radical agents, cationic, anionic or nonionic polymers, soluble or dispersed, or a mixture of these compounds.
- saccharides oligosaccharides, hydrolyzed or unmodified polysaccharides, modified or not
- saccharide isomerate amino acids, oligopeptides, peptides, hydrolyzed or unmodified proteins, modified or not, branched or unbranched fatty acids and alcohols, animal, vegetable or mineral oils or waxes
- additives are optionally present in the composition according to the invention in proportions which may range from 0.00001 to 30% by weight relative to the total weight of the composition.
- the precise amount of each additive is easily determined by a person skilled in the art according to its nature and its function.
- the composition according to the invention can comprise one or more agents which are beneficial for the skin or the coat, and in particular moisturizing agents, for example chosen from panthenol, saccharide isomerate, and / or glycerin.
- moisturizing agents for example chosen from panthenol, saccharide isomerate, and / or glycerin.
- Panthenol can be present in the composition in a content ranging from 0.1 to 3% by weight, relative to the total weight of the composition.
- the isomerate saccharide can be present in the composition in a content ranging from 0.001 to 1% by weight, relative to the total weight of the composition.
- These shampoo-type compositions can be in the form of more or less thickened liquids, and they are mainly suitable for washing and caring for keratin materials, in particular the coat or the skin of non-human mammals.
- a subject of the invention is also a method for cleaning and / or washing the skin and / or the coat of a non-human mammal, and in particular a dog or a cat, by applying the composition of the present invention to the skin. and / or the coat of said mammal.
- compositions according to the invention are implemented by simple application to the non-human mammal, optionally after having wetted all or part of the non-human mammal with water, and the foam generated, optionally by massage or friction. with the hands, is then removed, after a possible pause time, by rinsing with water, the operation being able to be repeated one or more times.
- a subject of the invention is also a process for washing and conditioning the coat and / or the skin of the non-human mammal, comprising the application of a composition as defined above, then in rinsing with the skin. water, after a possible pause time.
- the skin and / or the coat are advantageously wet prior to the application of the composition according to the invention.
- the method according to the invention also makes it possible not to be irritating, or even to reduce the irritation of the skin, which decreases the stress and gives a well-being effect to the non-human mammal, in particular the dog or the cat. . It also makes it possible to preserve, or even improve, the barrier function of the skin, in particular by virtue of the reduction in irritation, and / or the silky appearance of the coat.
- the shampoo-type compositions according to the invention for non-human mammals and in particular dogs and cats allow effective washing while preserving, or even improving, the barrier function of the skin and / or the coat and / or the appearance. silky coat.
- the shampoo-type compositions according to the invention for non-human mammals and in particular dogs and cats also make it possible to reduce the presence of pathogenic bacteria or their development or to reduce and / or prevent the formation and / or adhesion of biofilms of pathogenic bacteria, the pathogenic bacteria being in particular Staphylococcus aureus and / or Staphylococcus pseudintermedius.
- Another subject of the invention relates to the use of a composition as defined above or to a process using said composition for reducing and / or preventing the formation and / or adhesion of biofilms of pathogenic bacteria or for reducing the presence on the skin or the coat of pathogenic bacteria, such as Staphylococcus aureus and / or Staphylococcus pseudintermedius, in a non-human mammal, in particular the dog or cat.
- pathogenic bacteria such as Staphylococcus aureus and / or Staphylococcus pseudintermedius
- compositions as defined above or a method using said composition to reduce and / or prevent the formation and / or adhesion of biofilms of pathogenic bacteria or to decrease the presence of pathogenic bacteria can be carried out by applying a composition as defined above, then by rinsing with water, after a possible pause time.
- the skin and / or the coat are advantageously wet prior to the application of the composition according to the invention.
- the non-human mammal is chosen from felids, canines and / or equines, and in particular dogs and cats.
- the expression “comprises” or “comprising” is “open” and can be interpreted generally as such so that the specifically mentioned features and all optional, additional and unspecified features are included. According to specific embodiments, it can also be interpreted as an expression “consisting essentially of” in which are included the specified characteristics and any optional, additional or unspecified characteristic which does not materially affect the fundamental and new characteristic (s) of. the claimed invention, or as a phrase “consisting of” where only the features specified are included, unless otherwise specified.
- the term “at least one” means “one”, “two”, three ”, or more.
- compositions in Tables 1 to 4 are prepared according to conventional shampoo preparation methods. These compositions have good washing properties. They make it possible to improve the barrier function, to restore the microbial balance, and in particular to reduce the presence of pathogenic bacteria in dogs or cats, and also to limit the adhesion or the formation of biofilm.
- the pathogenic bacteria are in particular Staphylococcus aureus and / or Staphylococcus pseudintermedius.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19212292 | 2019-11-28 | ||
PCT/EP2020/083607 WO2021105339A1 (fr) | 2019-11-28 | 2020-11-27 | Compositions vétérinaires de type shampooing |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4065234A1 true EP4065234A1 (fr) | 2022-10-05 |
Family
ID=68732759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20811371.2A Pending EP4065234A1 (fr) | 2019-11-28 | 2020-11-27 | Compositions vétérinaires de type shampooing |
Country Status (8)
Country | Link |
---|---|
US (1) | US20230293424A1 (fr) |
EP (1) | EP4065234A1 (fr) |
JP (1) | JP2023503362A (fr) |
CN (1) | CN114980977A (fr) |
AU (1) | AU2020392432A1 (fr) |
BR (1) | BR112022010374A2 (fr) |
CA (1) | CA3159719A1 (fr) |
WO (1) | WO2021105339A1 (fr) |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1638082C3 (de) | 1968-01-20 | 1974-03-21 | Fa. A. Monforts, 4050 Moenchengladbach | Verfahren zum Entspannen einer zur Längenmessung geführten, dehnbaren Warenbahn |
US4031307A (en) | 1976-05-03 | 1977-06-21 | Celanese Corporation | Cationic polygalactomannan compositions |
FR2774900B1 (fr) * | 1998-02-13 | 2000-03-31 | Ceca Sa | Shampoings antipelliculaires transparents |
FR2837697B1 (fr) * | 2002-03-28 | 2005-01-28 | Oreal | Composition cosmetique moussante ; utilisations pour le nettoyage ou le demaquillage |
FR2930729B1 (fr) * | 2008-04-30 | 2013-08-16 | Limousine D Applic Biolog Ditesilab Soc Ind | Utilisation cosmetique d'un actif issu d'ophiopogon japonicus |
JP6666062B2 (ja) * | 2014-05-30 | 2020-03-13 | ロレアル | 起泡性クレンジング |
FR3046541B1 (fr) * | 2016-01-12 | 2018-02-09 | Societe Industrielle Limousine D'application Biologique | Principe actif obtenu a partir d'ophiopogon japonicus pour le traitement de la dermatite atopique |
EP3443951B8 (fr) * | 2016-04-11 | 2022-11-02 | Sabo S.p.A. | Agent surgraissant et composition de soin personnel |
CN106344467A (zh) * | 2016-11-25 | 2017-01-25 | 蔡银中 | 一种助眠的婴儿香波 |
EP3369459A1 (fr) * | 2017-03-01 | 2018-09-05 | The Boots Company PLC | Kit de compositions cosmétiques de soins pour la peau |
CN107157876A (zh) * | 2017-05-16 | 2017-09-15 | 广州市柏亚化妆品有限公司 | 一种用于提高头发色泽和新生头发的洗发水 |
CN107982135A (zh) * | 2017-12-25 | 2018-05-04 | 深圳市芭格美生物科技有限公司 | 一种洗发水及其制备方法 |
CN109731071A (zh) * | 2019-03-13 | 2019-05-10 | 贵州朗佑堂制药有限公司 | 一种皮肤屏障修复弱酸药浴乳 |
-
2020
- 2020-11-27 CA CA3159719A patent/CA3159719A1/fr active Pending
- 2020-11-27 JP JP2022531338A patent/JP2023503362A/ja active Pending
- 2020-11-27 BR BR112022010374A patent/BR112022010374A2/pt unknown
- 2020-11-27 CN CN202080090640.XA patent/CN114980977A/zh active Pending
- 2020-11-27 US US17/780,749 patent/US20230293424A1/en active Pending
- 2020-11-27 WO PCT/EP2020/083607 patent/WO2021105339A1/fr unknown
- 2020-11-27 AU AU2020392432A patent/AU2020392432A1/en active Pending
- 2020-11-27 EP EP20811371.2A patent/EP4065234A1/fr active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021105339A1 (fr) | 2021-06-03 |
BR112022010374A2 (pt) | 2022-08-16 |
CA3159719A1 (fr) | 2021-06-03 |
AU2020392432A1 (en) | 2022-06-23 |
US20230293424A1 (en) | 2023-09-21 |
JP2023503362A (ja) | 2023-01-27 |
CN114980977A (zh) | 2022-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2275265C (fr) | Composition conditionnante et detergente et utilisation | |
FR2966364A1 (fr) | Composition cosmetique comprenant de l'aloe vera et un derive d'acide isethionique | |
FR3029779A1 (fr) | Composition cosmetique comprenant des olefine sulfonates lineaires, des tensioactifs anioniques non oxyalkylenes, et des tensioactifs non ioniques et/ou amphoteres, et procede de traitement cosmetique | |
FR3076716A1 (fr) | Traitements capillaires avec action antipelliculaire | |
FR3029778A1 (fr) | Composition cosmetique comprenant des alpha-olefine sulfonates lineaires, des tensioactifs anioniques et des tensioactifs non ioniques et/ou ampho-teres, et procede de traitement cosmetique | |
EP4069181A1 (fr) | Compositions cosmetiques nettoyantes sous forme de poudre | |
EP3773443A1 (fr) | Utilisation d'une nouvelle composition pour empêcher ou ralentir l'apparition de signes d'inflammation | |
EP1148863B2 (fr) | Compositions cosmetiques detergentes et utilisation | |
FR3073142A1 (fr) | Formulation cosmetique | |
FR2785181A1 (fr) | Compositions cosmetiques detergentes et utilisation | |
EP4065234A1 (fr) | Compositions vétérinaires de type shampooing | |
CA2585914A1 (fr) | Composition cosmetique comprenant un ester de sorbitol oxyethylene et une cyclodextrine, procedes et utilisations | |
FR3013966A1 (fr) | Gel aqueux moussant comprenant un sulfoacetate d'alkyle, un alkyl polyglucoside, et eventuellement un sel d'acide gras sulfonates | |
FR3110409A1 (fr) | « Compositions nettoyantes à forte proportion de composants naturels » | |
CA3159722A1 (fr) | Compositions veterinaires non rincees | |
FR2785800A1 (fr) | Compositions cosmetiques contenant un tensioactif d'alkylpolyglycoside anionique, une gomme de galactomannane et leurs utilisations | |
EP2359800B1 (fr) | Composition de traitement cosmetique des fibres keratiniques a base d'alcane(s) lineraire(s) volatil(s), d'alcool(s) gras en C8-30 et de mono- ou polyglycoside(s) | |
FR2983728A1 (fr) | Composition cosmetique comprenant une combinaison de mannane de konjac et de gellane et utilisations | |
FR3115198A1 (fr) | Composition cosmétique nettoyante comprenant deux tensioactifs, un diol spécifique et un fructane | |
WO2023144487A1 (fr) | Ingredient protecteur de la peau et/ou des muqueuses contre les facteurs de virulence | |
FR3136977A1 (fr) | Composition lavante pour les fibres keratiniques comprenant au moins un tensioactif anionique, au moins un tensioactif amphotere ou zwitterionique et au moins un compose glucamide | |
FR3016291A1 (fr) | Composition comprenant au moins un monosaccharide et un extrait de bacterie filamenteuse | |
FR2785795A1 (fr) | Compositions cosmetiques contenant un tensioactif ester d'alkylpolyglycoside anionique et un ceramide et leurs utilisations | |
FR3110407A1 (fr) | « Agents nettoyants cosmétiques naturels contenant du caprylate de propanediol » | |
FR3136978A1 (fr) | Composition lavante pour les fibres keratiniques comprenant au moins un glucamide, un ester de (poly)glycerol et un alkyl(poly)glycoside |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20220531 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230530 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20240417 |